Jack Nathan Medical Corp.

TSXV:JNH Stock Report

Market Cap: CA$2.6m

Jack Nathan Medical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Jack Nathan Medical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth61.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%

Aug 12
Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%

Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%

Jun 28
Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%

Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Feb 07
Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Oct 27
Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

Dec 31
Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Jack Nathan Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSXV:JNH - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
7/31/202421-9-10-7N/A
4/30/202420-8-12-8N/A
1/31/202419-7-10-6N/A
10/31/202317-8-9-5N/A
7/31/202317-7-8-4N/A
4/30/202316-6-5-2N/A
1/31/202315-7-5-2N/A
10/31/202216-6-2-1N/A
7/31/202214-7-3-3N/A
4/30/202212-8-5-4N/A
1/31/202210-8-5-4N/A
10/31/20216-7-5-4N/A
7/31/20215-14-4-3N/A
4/30/20214-11-2-2N/A
1/31/20214-10-1-1N/A
10/31/20204-900N/A
7/31/20204000N/A
4/30/20204-200N/A
1/31/20204-1-10N/A
1/31/20193200N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if JNH's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if JNH's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if JNH's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if JNH's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if JNH's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if JNH's Return on Equity is forecast to be high in 3 years time


Discover growth companies